HKU Scholars Hub: Browsing DSpace

Browsing by Author Liaw, YF

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 20 of 25 next >

Title	Author(s)	Issue Date
12 months lamivudine (100mg od) therapy improves liver histology: results of a placebo controlled multicentre study in Asia Proceeding/Conference:Journal of Hepatology	Lai, CL Liaw, YF Leung, NWY Chang, TT Guan, R Tai, DI Ng, KY Wu, PC Dent, JC Gray, DF	1997
A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment Journal:Journal of Immunological Methods	Tsai, SL Lee, TH Chien, RN Liao, SK Lin, CL Kuo, GC Liaw, YF	2004
Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: revisited with tetramers assay and therapeutic implications Journal:Journal of Biomedical Science	Tsai, SL Sheen, IS Chien, RN Chu, CM Huang, HC Chuang, YL Lee, TH Liao, SK Lin, CL Kuo, GC Liaw, YF	2003
Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma Journal:Hepatology International	Omata, M Lesmana, LA Tateishi, R Chen, PJ Lin, SM Yoshida, H Kudo, M Lee, JM Choi, BI Poon, RTP Shiina, S Cheng, AL Jia, JD Obi, S Han, KH Jafri, W Chow, P Lim, SG Chawla, YK Budihusodo, U Gani, RA Lesmana, CR Putranto, TA Liaw, YF Sarin, SK	2010
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update Journal:Liver International	Liaw, YF Leung, N Guan, R Lau, GKK Merican, I McCaughan, G Gane, E Kao, JH Omata, M	2005
Association between HBeAg seroconversion and sustained HBV-DNA suppression in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) for HBeAg-positive chronic hepatitis B (CHB) Proceeding/Conference:Journal of Hepatology	Piratvisuth, T Lau, GKK Marcellin, P Chow, WC Cooksley, G Fried, MW Paik, SW Liaw, YF Popescu, M Button, P	2006
Effect of core promoter/precore mutation pattern and early virologic response on efficacy outcomes with telbivudine in HBeAg-negative chronic hepatitis B Proceeding/Conference:Journal of Hepatology	Naoumov, N Lai, CL Gane, E Liaw, YF Thongsawat, S Wang, YM Heathcote, EJ Rasenack, J Bzowej, N Chao, G Brown, N	2006
Effects of extended lamivudine therapy in asian patients with chronic hepatitis B Journal:Gastroenterology	Liaw, YF Leung, NWY Chang, TT Guan, R Tai, DI Ng, KY Chien, RN Dent, J Roman, L Edmundson, S Lai, CL	2000
eGFR Improvement In Chronic Hepatitis B Patients With Telbivudine Treatment Is Independent Of Antiviral Activity Proceeding/Conference:Journal of Hepatology	Gane, EJ Liaw, YF Wang, Y Lai, CL Rasenack, J Zeuzem, S Chan, HLY Ren, H Dong, Y Uddin, A Jung, ME Bosset, S Trylesinski, A	2013
Entecavir (ETV) vs. Adefovir (ADV): HBV DNA reduction of viral load in chronically infected HBeAg(+) nucleoside naive adults in a 12-week Proceeding/Conference:Journal of clinical virology	Sherman, M Hann, HW Jeffers, L Min, A Leung, N Peng, CY Liaw, YF Sollano, J Lesmana, L Yuen, RMF Zhu, J Mencarini, K Colonno, R Cross, A Wilber, R Lopez-Talavera, JC	2006
Evaluation of Estimated Glomerular Filtration Rate During Continuous 4-Year Treatment with Telbivudine in Patients with Bridging Fibrosis/Cirrhosis Proceeding/Conference:Journal of Hepatology	Gane, EJ Lai, CL Xie, Q Liaw, YF Thongsawat, S Chan, HLY Wang, Y Hwang, SG Safadi, R Jung, M Uddin, A Janssens, N Trylesinski, A	2014
High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B	Lin, CL Tsai, SL Lee, TH Chien, RN Liao, SK Liaw, YF	2005
Long-term entecavir therapy results in reversal of fibrosis/cirrhosis and continued histologic improvement in patients with HBeAg(+) and (-) chronic hepatitis B: results from studies ETV-022, -027 and -901 Proceeding/Conference:Hepatology	Liaw, YF Chang, TT Wu, SS Schiff, ER Han, KH Lai, CL Safadi, R Lee, SS Halota, W Goodman, ZD Zhang, H Hindes, R Iloeje, U Beebe, S Kreter, B	2008
Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B Journal:Hepatology	Chang, TT Liaw, YF Wu, SS Schiff, E Han, KH Lai, CL Safadi, R Lee, SS Halota, W Goodman, Z Chi, YC Zhang, H Hindes, R Iloeje, U Beebe, S Kreter, B	2010
Long-term follow-up of entecavir treated protocol-defined non responders in rollover study ETV-901 Proceeding/Conference:Hepatology	Sherman, M Rizzetto, M Lai, CL Liaw, YF Gadano, A Jacobson, IM Schiff, ER Yang, J Colonno, R Kreter, B Hindes, R	2007
Long-Term Histologic Improvement with Entecavir (ETV) Therapy in Patients with Chronic Hepatitis B (CHB) from Japanese and Worldwide Development Programs Proceeding/Conference:Gastroenterology	Liaw, YF Chang, TT Wu, SS Schiff, ER Kan, KH Lai, CL Safadi, R Lee, SS Halota, W Goodman, ZD Zhang, H Iloeje, UH Beebe, S Kreter, B Ishikawa, H Katano, Y Takaguchi, K Omata, M	2009
Maximal early HBV suppression is predictive of optimal virologic and clinical efficacy in nucleoside-treated hepatitis B patients: scientific observations from a large multinational trial (the GLOBE study) Proceeding/Conference:Hepatology	Lai, CL Gane, E Liaw, YF Thongsawat, S Wang, YM Chen, Y Heathcote, J Rasenack, J Bzowej, N Naoumov, N Chao, G Fielman, B Brown, N the GLOBE Study Group	2005
Optimal virologic and clinical efficacy at one year is associated with maximal early HBV suppression in nucleoside-treated hepatitis B patients Proceeding/Conference:Journal of Hepatology	Zeuzem, S Lai, CL Gane, E Liaw, YF Thongsawat, S Wang, YM Chen, Y Heathcote, J Rasenack, J Bzowej, N Naoumov, N Chao, G Fielman, B Brown, N	2006
Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year Proceeding/Conference:Journal of Hepatology	Gane, E Lai, CL Liaw, YF Thongsawat, S Wang, YM Cheng, Y Heathcote, J Rasenack, J Bzowej, N Naoumov, N Chao, G Fielman, B Brown, N	2006
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B Journal:Hepatology	Perrillo, RP Lai, CL Liaw, YF Dienstag, JL Schiff, ER Schalm, SW Heathcote, EJenny Brown, NA Atkins, M Woessner, M Gardner, SD	2002

Showing results 1 to 20 of 25 next >